Subcutaneously Administered Ofatumumab in Rheumatoid Arthritis: A Phase I/Ii Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics
Journal of Rheumatology - Canada
doi 10.3899/jrheum.121118
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2013
Authors
Publisher
The Journal of Rheumatology